4.2 Article

Trends in risks of malignancies in Japanese patients with rheumatoid arthritis: Analyses from a 14-year observation of the IORRA cohort

期刊

MODERN RHEUMATOLOGY
卷 33, 期 4, 页码 715-722

出版社

OXFORD UNIV PRESS
DOI: 10.1093/mr/roac085

关键词

Lung cancer; malignancy; malignant lymphoma; rheumatoid arthritis; standardized incidence ratio

向作者/读者索取更多资源

The study investigated the trends in risks of malignancies in patients with rheumatoid arthritis (RA) in Japan. The results showed that there was no increase in malignancy risk in Japanese patients with RA, despite the expanding use of methotrexate and biologics. The overall risk for malignancies was similar to the general Japanese population, while the risk for malignant lymphoma was significantly increased.
Objectives The aim is to investigate the trends in risks of overall and site-specific malignancies in patients with rheumatoid arthritis (RA). Methods Among Japanese patients with RA enrolled in the Institute of Rheumatology, Rheumatoid Arthritis cohort, all malignancies that occurred from 2000 to 2013 were extracted. The standardized incidence ratios and 95% confidence intervals for overall and site-specific malignancies were calculated during three periods: pre-biologics, 2000-04; early biologics, 2005-09; and recent biologics, 2010-13. Risk factors for overall and specific malignancies were analysed using time-dependent Cox regression models. Results Among 11,299 patients with RA (68,483 person-years), 507 malignancies were confirmed. Similar risks were observed versus the general Japanese population for overall malignancies throughout the three periods, with standardized incidence ratios (95% confidence intervals) of 0.96 (0.80-1.14) in the pre-biologics period, 0.95 (0.82-1.09) in the early biologics period, and 0.87 (0.75-1.01) in the recent biologics period. A significantly increased risk for malignant lymphoma was observed throughout the observation period (standardized incidence ratio 4.61, 95% confidence interval 3.58-5.85). The disease activity was a significant risk factor for overall malignancies and lung cancer. Conclusions Despite the expanding use of methotrexate and biologics, there were no increases in malignancy risk in Japanese patients with RA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据